Cargando…
A temperature-sensitive phase-change hydrogel of tamoxifen achieves the long-acting antitumor activation on breast cancer cells
Background: Breast cancer is one of the foremost threats to female health nowadays. Tamoxifen, an antagonist of estrogen receptor-α (ERα), is the first choice for endocrine-dependent breast cancer (ERα-positive breast cancer) treatment. However, ERα has an important function in the normal physical r...
Autores principales: | Meng, Du, Lei, Hongwei, Zheng, Xiaoqiang, Han, Yaxuan, Sun, Ronggang, Zhao, Dongli, Liu, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538837/ https://www.ncbi.nlm.nih.gov/pubmed/31213826 http://dx.doi.org/10.2147/OTT.S201421 |
Ejemplares similares
-
A temperature-sensitive phase-change hydrogel of topotecan achieves a long-term sustained antitumor effect on retinoblastoma cells
por: Huo, Yan, et al.
Publicado: (2019) -
Effects of temperature on the fracture and fatigue damage of temperature sensitive hydrogels
por: Zhang, Ni, et al.
Publicado: (2018) -
Tamoxifen Acts as a Parietal Cell Protonophore
por: Manning, E.H., et al.
Publicado: (2020) -
Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to
Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021) -
MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells
por: Meng, Du, et al.
Publicado: (2018)